Back to search

Article

Evaluating the Efficacy of Finerenone in Reducing Proteinuria in Diabetic Nephropathy Patients Receiving Maximum Tolerable Doses of Dapagliflozin and Telmisartan

2025-07-18

Abstract excerpt

<title>Abstract</title> <p>Background Diabetic nephropathy (DN) remains a leading cause of end-stage renal disease (ESRD), with persistent proteinuria contributing to renal and cardiovascular complications. Despite dual therapy with renin-angiotensin-aldosterone system (RAAS) blockers and sodium-glucose co-transporter-2 inhibitors (SGLT2is), residual proteinuria persists in a substantial subset of patients. Finer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c8d7789-2127-563e-be69-05bae562b19d
DOI
10.21203/rs.3.rs-7053853/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluating the Efficacy of Finerenone in Reducing Proteinuria in Diabetic Nephropathy Patients Receiving Maximum Tolerable Doses of Dapagliflozin and TelmisartanDOI 10.21203/rs.3.rs-7053853/v1
Cardiorenal Outcomes with Finerenone in Patients Post-Acute Myocardial Infarction: Insights from a Global Federated NetworkSemantic proximity
Functional Renal Reserve-Guided Personalized Renoprotection in Chronic Kidney Disease: Extending the KDIGO CGA FrameworkSemantic proximity
Diabetic nephropathy.Semantic proximity
Cardiorenal outcomes of tirzepatide versus semaglutide in adults with type 2 diabetes and chronic kidney disease: a target trial emulation in the TriNetX Global Collaborative NetworkSemantic proximity
Chronic Kidney Disease in the Elderly Patient with DiabetesSemantic proximity
Early mineralocorticoid receptor antagonism in diabetic nephropathy limits albuminuria by preserving the glomerular endothelial glycocalyxSemantic proximity
Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.Semantic proximity
Mineralocorticoid Receptor/Rac1-Driven Podocyte Injury in Fabry Disease: Finerenone and Spironolactone migitate the overactive signaling cascadeSemantic proximity
The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: Protocol for a Systematic Review.Semantic proximity
Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.Semantic proximity
Exenatide and renal outcomes in patients with type 2 diabetes and diabetic kidney disease: a multi-center, randomized, parallel studySemantic proximity
Effect of SGLT2 Inhibitors on CKD Progression and All-Cause Mortality: A Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Select a neighboring publication to make it the new centre.